PDF
(Download)
|
- Green Tea (Camellia
sinensis)
- Aloe (Aloe vera)
- Isoflavones
| Date:
04-13-2012 | HC# 011233-446
|
Re: Health Benefits of Green Tea, Isoflavones, and Aloe Reviewed
Williamson
G, Coppens P, Serra-Majem L, Dew T. Review of the efficacy of green tea,
isoflavones and aloe vera supplements based on randomised controlled trials. Food Funct. December 2011;2(12):753-759.
Various
botanicals and their preparations and derivatives are used in products promoted
for their beneficial health effects. These European authors conducted a review
of the literature to assess the evidence for health benefits of three commonly
used plant food supplements (PFS): green tea (Camellia sinensis) (12 studies or reviews cited), isoflavones (23
studies or reviews cited), and aloe (Aloe
vera) (9 studies or reviews
cited).
The
authors explain that because the criteria applied by the European Food Safety
Authority to evaluate the health effects of food components relies on the
well-defined characterization of the food component and measurable biomarkers,
it can only be applied to well-defined extracts or pure compounds isolated from
plant material. Its application to botanicals and botanical preparations is
limited because the compounds responsible for specific effects are not
identified and the effects may be diffused and not linked to specific markers.
For the continued use of botanicals, traditional use has been suggested as a
valid and essential element of the totality of evidence to substantiate health
effects. The authors discuss proposed criteria relating to the various sources
of documentation for traditional use.1
The
authors' review includes many studies indicating that green tea has positive
effects in various health areas, including metabolic syndrome, cognitive
function and neuroprotection, cancer, bone health, and arthritis.
Unfortunately, say the authors, there are few health areas where sufficient randomized,
controlled trials (RCTs) have been conducted to properly judge the efficacy of oral
green tea intervention. In a meta-analysis of 133 RCTs on flavonoid-rich foods
and cardiovascular disease risk factors, green tea consumption significantly
reduced low-density lipoprotein cholesterol.2 Other systematic
reviews and meta-analyses consider green, black, and oolong teas together,
consumed as both infusions and extracts. "It is only in the area of the metabolic
syndrome that the number of RCTs indicated is approaching sufficient to judge
such efficacy," write the authors. For example, in a meta-analysis of 11
green tea intervention studies with 1,226 participants, green tea catechins
plus caffeine were effective in promoting weight loss and maintaining weight
after a period of negative energy balance.3 The importance of
caffeine was also highlighted in a meta-analysis4 of 15 trials with
1,243 participants, in which green tea catechins taken alone had no significant
effect on the endpoints (body weight, waist circumference, waist-to-hip ratio,
and body mass index), but green tea catechins combined with caffeine
significantly decreased body weight compared with a noncaffeinated control. In
that same analysis, body weight, waist circumference, and body mass index were
all decreased by green tea catechins plus caffeine intervention compared with a
caffeine control.
RCTs
indicate that isoflavones can affect bone resorption at lower doses in
postmenopausal women with estrogen-related bone loss, but "this is only
translated to attenuation of bone loss at higher doses of isoflavones,"
say the authors. They cite a review5 of 28 studies involving 2,477
subjects in RCTs and a meta-analysis6 of nine RCTs using 432
subjects.
The
effects of isoflavones on bone mineral density are less clear. A cited
systematic review of 12 studies involving 1,433 subjects7 and a
meta-analysis of 10 studies using 608 subjects8 offered conflicting
results. The authors' review of RCTs (which included five systematic reviews of
99 studies) concluded that the effects of isoflavones on hot flashes in
postmenopausal women were variable and that no firm conclusions could be made.
"Despite
the popularity of aloe as a PFS, the evaluation of its efficacy as a coadjuvant
therapy for certain metabolic or digestive pathologies remains scarce," state
the authors. It is a typical example of a naturally occurring ingredient whose
efficacy in topical applications presupposes its efficacy in oral applications.
Nonrandomized, clinical trials and case reports suggest the use of aloe in
improving fasting blood glucose levels. In a cited review9 of eight
trials with 5,285 subjects, the evidence suggests a trend toward the benefit of
oral aloe use in reducing fasting blood glucose concentration. Although there
are some promising results with the use of aloe for diverse dermatological
conditions, say the authors, its clinical effectiveness has not been
sufficiently studied. A certain degree of efficacy was demonstrated for aloe
gel in the treatment of oral lichen planus in a well-designed RCT,10,11
and a systematic review supported the use of aloe as an effective intervention
in burn wound healing for first- to second-degree burns.12 The
authors note that aloe ingestion has been associated with diarrhea, electrolyte
imbalance, kidney dysfunction, and interactions with conventional drugs, and
that its topical use has been associated with episodes of contact dermatitis,
erythema, and phototoxicity.
The
authors conclude that, in general, conclusive results on PFS should be
established in the future by conducting studies with more homogeneous
populations, by using supplements with optimized and measured bioavailibility,
and by conducting larger RCTs using validated biomarkers for as long as needed
to make conclusive results on a putative effect.
―Shari
Henson
References
1Anton R, Serafini M,
Delmulle L. Food Sci Technol Bull.
2011. In press. [Note: The authors of the original article did not provide the title
name for this citation. A search of the Internet also provided no results.]
2Hooper L, Kroon PA, Rimm
EB, et al. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a
meta-analysis of randomized controlled trials. Am J Clin Nutr. 2008;88(1):38-50.
3Hursel R, Viechtbauer W,
Westerterp-Plantenga MS. The effects of green tea on weight loss and weight
maintenance: a meta-analysis. Int J Obes (Lond). 2009 Sep;33(9):956-961.
4Phung OJ, Baker WL,
Matthews LJ, Lanosa M, Thorne A, Coleman CI. Effect of green tea catechins with
or without caffeine on anthropometric measures: a systematic review and
meta-analysis. Am J Clin Nutr.
2010;91(1):73-81.
5Taku K, Melby MK, Kurzer
MS, Mizuno S, Watanabe S, Ishimi Y. Effects of soy isoflavone supplements on bone turnover
markers in menopausal women: systematic review and meta-analysis of randomized
controlled trials. Bone.
2010;47(2):413-423.
6Ma DF, Qin LQ, Wang PY,
Katoh R. Soy isoflavone intake inhibits bone resorption and stimulates bone
formation in menopausal women: meta-analysis of randomized controlled trials. Eur J Clin Nutr. 2008;62(2):155-161.
7Ricci E, Cipriani S,
Chiaffarino F, Malvezzi M, Parazzini F. Soy isoflavones and bone mineral
density in perimenopausal and postmenopausal Western women: a systematic review
and meta-analysis of randomized controlled trials. J Womens Health (Larchmt). 2010;19(9):1609-1617.
8Ma DF, Qin LQ, Wang PY,
Katoh R. Soy isoflavone intake increases bone
mineral density in the spine of menopausal women: meta-analysis of randomized
controlled trials. Clin Nutr. 2008;27(1):57-64.
9Ngo MQ, Nguyen NN, Shah
SA. Oral aloe vera for treatment of diabetes mellitus and dyslipidemia. Am J Health Syst Pharm. 2010;67(21):1804-1811.
10Feily A, Namazi MR. Aloe
vera in dermatology: a brief review. G
Ital Dermatol Venereol. 2009;144(1):85-91.
11Choonhakarn C,
Busaracome P, Sripanidkulchai B, Sarakarn P. The efficacy of aloe vera gel in
the treatment of oral lichen planus: a randomized controlled trial. Br J Dermatol. 2008;158(3):573-577.
12Maenthaisong
R, Chaiyakunapruk N, Niruntraporn S, Kongkaew C. The efficacy of aloe vera used
for burn wound healing: a systematic review. Burns. 2007;33(6):713-718.
|